A three-line lateral flow assay strip for the measurement of C-reactive protein covering a broad physiological concentration range in human sera

2014 ◽  
Vol 61 ◽  
pp. 285-289 ◽  
Author(s):  
Young Kyoung Oh ◽  
Hyou-Arm Joung ◽  
Hyung Soo Han ◽  
Ho-Jun Suk ◽  
Min-Gon Kim
2019 ◽  
Vol 35 (3) ◽  
pp. 257-263 ◽  
Author(s):  
Nan ZHAN ◽  
Yang ZHOU ◽  
Laibao MEI ◽  
Yuwang HAN ◽  
Hongman ZHANG

2020 ◽  
Vol 22 (11) ◽  
pp. 617-629
Author(s):  
Ngoc Linh Phung ◽  
Johanna G. Walter ◽  
Rebecca Jonczyk ◽  
Lisa K. Seiler ◽  
Thomas Scheper ◽  
...  

The Analyst ◽  
2018 ◽  
Vol 143 (9) ◽  
pp. 2115-2121 ◽  
Author(s):  
Zhen Rong ◽  
Rui Xiao ◽  
Shuang Xing ◽  
Guolin Xiong ◽  
Zuyin Yu ◽  
...  

We demonstrate a SERS-based lateral flow assay for rapid and quantitative detection of CRP and its potential for in-field evaluation of acute radiation syndrome.


2008 ◽  
Vol 336 (1) ◽  
pp. 30-36 ◽  
Author(s):  
Wingman Leung ◽  
Cangel Puiyee Chan ◽  
Timothy H. Rainer ◽  
Margaret Ip ◽  
George W.H. Cautherley ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-6 ◽  
Author(s):  
Kenji Inoue ◽  
Tatsuhiko Kodama ◽  
Hiroyuki Daida

Numerous studies have recently examined the role of pentraxin 3 (PTX3) in clinical situations. The pentraxin family includes C-reactive protein (CRP); however, unlike CRP, PTX3 is expressed predominantly in atherosclerotic lesions that involve macrophages, neutrophils, dendritic cells, or smooth muscle cells. Interestingly, PTX3 gene expression in human endothelial cells is suppressed to a greater extent by pitavastatin than the expression of 6,000 other human genes that have been examined, suggesting that PTX3 may be a novel biomarker for inflammatory cardiovascular disease. The expression and involvement of PTX3 in cardiovascular diseases are discussed in this paper, along with the characteristics of PTX3 that make it a suitable biomarker; namely, that the physiological concentration is known and it is independent of other risk factors. The results discussed in this paper suggest that further investigations into the potential novel use of PTX3 as a biomarker for inflammatory cardiovascular disease should be undertaken.


Sign in / Sign up

Export Citation Format

Share Document